1887

Abstract

Descriptive clinical data help to reveal factors that may provoke Zika virus (ZIKV) neuropathology. The case of a 24-year-old female with a ZIKV-associated severe acute neurological disorder was studied. The levels of ZIKV in the cerebrospinal fluid (CSF) were 50 times higher than the levels in other compartments. An acute anti-flavivirus IgG, together with enhanced TNF-alpha levels, may have contributed to ZIKV invasion in the CSF, whereas the unbiased genome sequencing [obtained by next-generation sequencing (NGS)] of the CSF revealed that no virus mutations were associated with the anatomic compartments (CSF, serum, saliva and urine).

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001080
2018-05-17
2019-10-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/7/913.html?itemId=/content/journal/jgv/10.1099/jgv.0.001080&mimeType=html&fmt=ahah

References

  1. Calvet G, Aguiar RS, Melo ASO, Sampaio SA, de Filippis I et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016;16:653–660 [CrossRef][PubMed]
    [Google Scholar]
  2. Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet 2016;387:1531–1539 [CrossRef][PubMed]
    [Google Scholar]
  3. Driggers RW, Ho CY, Korhonen EM, Kuivanen S, Jääskeläinen AJ et al. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N Engl J Med 2016;374:2142–2151 [CrossRef][PubMed]
    [Google Scholar]
  4. Smith DW, Mackenzie J. Zika virus and Guillain-Barré syndrome: another viral cause to add to the list. Lancet 2016;387:1486–1488 [CrossRef][PubMed]
    [Google Scholar]
  5. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S et al. Zika virus infection complicated by Guillain-Barre syndrome–case report, French Polynesia, December 2013. Euro Surveill 2014;19:20720 [CrossRef][PubMed]
    [Google Scholar]
  6. Brasil P, Sequeira PC, Freitas AD, Zogbi HE, Calvet GA et al. Guillain-Barré syndrome associated with Zika virus infection. Lancet 2016;387:1482 [CrossRef][PubMed]
    [Google Scholar]
  7. Solomon T. Flavivirus encephalitis. N Engl J Med 2004;351:370–378 [CrossRef][PubMed]
    [Google Scholar]
  8. Valadão AL, Aguiar RS, de Arruda LB. Interplay between inflammation and cellular stress triggered by Flaviviridae viruses. Front Microbiol 2016;7:1233 [CrossRef][PubMed]
    [Google Scholar]
  9. Abbott NJ. Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 2005;25:5–23 [CrossRef][PubMed]
    [Google Scholar]
  10. Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 2017;358:929–932 [CrossRef][PubMed]
    [Google Scholar]
  11. Dahm T, Rudolph H, Schwerk C, Schroten H, Tenenbaum T. Neuroinvasion and inflammation in viral central nervous system infections. Mediators Inflamm 2016;2016:1–16 [CrossRef][PubMed]
    [Google Scholar]
  12. Garcez PP, Loiola EC, Madeiro da Costa R, Higa LM, Trindade P et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 2016;352:816–818 [CrossRef][PubMed]
    [Google Scholar]
  13. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14:1232–1239 [CrossRef][PubMed]
    [Google Scholar]
  14. Sacramento CQ, de Melo GR, de Freitas CS, Rocha N, Hoelz LV et al. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep 2017;7:40920 [CrossRef][PubMed]
    [Google Scholar]
  15. Dejnirattisai W, Supasa P, Wongwiwat W, Rouvinski A, Barba-Spaeth G et al. Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016;17:1102–1108 [CrossRef][PubMed]
    [Google Scholar]
  16. Terzian ACB, Schanoski AS, Mota MTO, da Silva RA, Estofolete CF et al. Viral load and cytokine response profile does not support antibody-dependent enhancement in dengue-primed Zika virus-infected patients. Clin Infect Dis 2017;65:1260–1265 [CrossRef][PubMed]
    [Google Scholar]
  17. Pantoja P, Pérez-Guzmán EX, Rodríguez IV, White LJ, González O et al. Zika virus pathogenesis in rhesus macaques is unaffected by pre-existing immunity to dengue virus. Nat Commun 2017;8:15674 [CrossRef][PubMed]
    [Google Scholar]
  18. Kam YW, Lee CY, Teo TH, Howland SW, Amrun SN et al. Cross-reactive dengue human monoclonal antibody prevents severe pathologies and death from Zika virus infections. JCI Insight 2017;2:92428 [CrossRef][PubMed]
    [Google Scholar]
  19. Castanha PMS, Nascimento EJM, Braga C, Cordeiro MT, de Carvalho OV et al. Dengue virus-specific antibodies enhance Brazilian Zika virus infection. J Infect Dis 2017;215:781–785 [CrossRef][PubMed]
    [Google Scholar]
  20. Ricciardi MJ, Magnani DM, Grifoni A, Kwon YC, Gutman MJ et al. Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naïve individual during the 2016 outbreak in Miami, FL. PLoS Negl Trop Dis 2017;11:e0006000 [CrossRef][PubMed]
    [Google Scholar]
  21. Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ et al. Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 2017;356:175–180 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001080
Loading
/content/journal/jgv/10.1099/jgv.0.001080
Loading

Data & Media loading...

Supplements

Supplementary File 2

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error